Abstract -Chronic and excessive exposure to UV radiation leads to photoaging and photocarcinogenesis. Adequate protection of the skin against the deleterious effects of UV irradiation is essential. Low-level laser therapy (LLLT) is a light source in the red to near-infrared range that has been accepted in a variety of medical applications. In this study, we explored the effect of LLLT in human face aged skin and the cell viability of HeLa cells exposed to UV radiation. We found that LLLT significantly reduced visible wrinkles and the loss of firmness of facial skin in aging subjects. Additionally, treatment of cultured HeLa cells with LLLT prior to or post UVA or UVB exposure significantly protected cells from UVmediated cell death. All results showed the beneficial effects of LLLT on relieving signs of skin aging and its prevention and protection of the cell viability against UV-induced damage.
INTRODUCTION
Skin aging is the result of the combination of intrinsic aging (chronological aging) and extrinsic aging induced by environmental factors, particularly solar ultraviolet radiation (actinic aging). Chronic and excessive ultraviolet (UV) radiation correlates with the development of skin photoaging, skin carcinoma and the suppression of skin immunity (Armstrong and Kricher, 2001; Godar, 2005; Yaar and Gilchrest, 2007; Karol, 2009; Fragkiski et al., 2012) . Extrinsic skin aging is characterized by elastosis in the upper dermis, destruction of its fibrillar structure and moderation of inflammatory infiltration (Yaar and Gilchrest, 2007; Fragkiski et al., 2012) . The UV component of the sunlight reaching the earth surface consists of 90% UVA and 10% UVB; the ozone layer blocks UVC and most of the UVB (80-90%). However, the depletion of the stratosphere ozone layer strongly increases the risk of skin exposure to the deleterious actions of UVB radiation (Garcia, 2011) . Both UVB and UVA radiation contribute to freckling, skin wrinkling, aging effects and the development of skin cancer (Kligman et al., 1985; Schober-Flores, 2001; Yaar and Gilchrest, 2007; Polefka et al., 2012) . Therefore, scientists are constantly searching for more powerful photoprotective agents for human skin to reduce UV-mediated injury to the skin and to relieve signs of aging.
Low-level laser therapy (LLLT) utilizes a light source that is usually red to near-infrared (wavelengths in the range of 630-904 nm). LLLT shows high penetration into tissues and has been used as a light source for multiple health treatments. The wavelengths used in low-level lasers have been demonstrated to enhance the remodeling and repair of bone, to improve the treatment of soft-tissue injuries, to stimulate wound healing, to restore normal neuronal function following injury and to treat tendinopathy and rheumatoid arthritis (Ty Hopkin et al., 2004; Corazza et al., 2007; Brosseau et al., 2010; Tumilty et al., 2010; Akgul et al., 2014) .
In this study, we assessed the putative effects of LLLT on facial skin wrinkles using a human model of aging persons. We also investigated the protective effects of LLLT against UVA-or UVB-induced cytotoxicity and cell death of human epithelioid HeLa cells.
MATERIALS AND METHODS

Cell culture and treatment
HeLa cells (human epithelial carcinoma cells) were cultured in 35 mm culture dishes and maintained in RPMI medium containing 2 mM L-glutamine (Gibco-BRL, France) supplemented with 10% fetal bovine serum (FBS) and 100 U/ml of penicillin-streptomycin (Gibco-BRL, France), in a humidified 5% CO 2 incubator at 37°C. After cell confluence, the culture medium was removed and replaced with fresh culture medium without serum. Then, one set of cells was exposed to UVB (0.001 W/cm 2 , LaboModerne) or to UVA (0.003 W/cm 2 , LaboModerne) and the other sets of cells were treated for 2 h with LLLT prior to or post UV radiation. Control cells were subjected to the identical procedure without exposure to UV or LLLT. Finally, one set of cells was irradiated only by LLLT to evaluate the cytotoxicity of LLLT radiation.
LLLT exposure system
Laser irradiation was performed with an ABYONIK R 500 diode laser (on a probe designed and built by Beauty Lumis, Munich Germany) with the following technical characteristics: the laser contained two wavelengths, working simultaneously, wavelength (λ) = 655 nm (red) and 785 nm (near-infrared), power = 5 mW. For studies conducted on cells, the probe was placed perpendicular to the dish, above the cell monolayer, and a homogeneous fluence was applied to the full extension of the dish.
Clinical study
Ten female subjects aged 40-65 years received LLLT. Irradiation was delivered to the face from a diode cluster head. The average energy density of the treatment was 27.77 J/cm 2 (treatment time 30 min; number of sessions depended on the patient's age). During treatment, the cluster head was centered over the wrinkles and held stationary while maintaining a 2-4 cm distance between the treatment head and the skin. Patients and personnel wore laser safety protection glasses during the treatment.
Cell viability assays
At the end of the treatment, the cell number was determined by counting the viable cells in a hemocytometer using the Trypan blue (Sigma-Aldrich, France) dye exclusion assay. Viability was expressed as a percentage of the control (not exposed). Four dishes of each group were counted. Cell cytotoxicity was quantified by measuring the lactate dehydrogenase (LDH) released in the culture supernatants from damaged cells using a commercially available kit (Biomaghreb, Tunisia).
Statistical analysis
The data are expressed as the means ± S.E.M and were evaluated using the Student's t-test. The differences were considered to be statistically significant when P = 0.05.
RESULTS
LLLT attenuates skin wrinkles and the loss of firmness in the faces of aging persons LLLT treatments were performed on 10 subjects aged from 40 to 65 years, exhibiting wrinkles and the loss of firmness facial skin. As shown in Fig. 1 , a women of 63 years, treated with LLLT for 30 min/ session (number of sessions 7) exhibited a significant attenuation of wrinkles and crow's feet, lines were visibly smoothed and the skin's volume and elasticity was largely restored. The success of LLLT radiation in reducing the signs of facial skin aging was detected in all subjects. The treatment is painless and risk-free.
LLLT exposure reduces UVA or UVB-induced cytotoxicity and cell death in HeLa cells
The results showed that cell viability significantly decreased after UVA or UVB irradiation by 28.2% and 20.48%, respectively, when compared with control cells (not exposed). However, the treatment of cells with LLLT prior to or post UVA or UVB irradiation increased cell viability. Pretreatment by laser radiation increased the viability of HeLa cells irradiated by UVA or UVB by 17.02% and 14.43%, respectively. Post-treatment by laser radiation increased the cell viability of cells exposed to UVA or UVB by 15.21% and 15.3%, respectively. The cell viability was 95% when cells were treated only with LLLT ( Fig. 2A) .
Furthermore, cytotoxicity was quantified by the measurement of LDH released to the culture media from injured cells. According to Fig. 2B , there was a significant increase in LDH leakage after UV exposure. This response was significantly reduced by the treatment of cells with LLLT prior to or post UV radiation. Pretreatment by laser radiation decreased the release of LDH from HeLa cells irradiated by UVA or UVB by 33.49% and 30.39%, respectively. Post-treatment by laser radiation decreased the LDH leakage from cells exposed to UVA or UVB by 29.51% and 29.38%, respectively. Irradiation with LLLT alone did not result in LDH release.
DISCUSSION
We initially investigated the effect of LLLT on the clinical signs associated with aged skin, including wrinkling, lines and the plumpness of the skin. These changes are considered to result from intrinsic aging associated with reduced cellular proliferative capacity and are accelerated by extrinsic factors, particularly sun exposure (Yaar and Gilchrest, 2007; Fragkiski et al., 2012) . Our results demonstrated that after treatment with LLLT radiation, persons aged from 40 to 65 years showed a significant attenuation of their wrinkles. and the skin's volume and elasticity was largely restored. Additionally, our investigation to assess the photoprotective effects of LLLT against UV-cell damage showed that the treatment of cells with LLLT prior to or post UVA or UVB irradiation increased cell viability. These results suggested that the pretreatment by LLLT radiation prevented cells from death and the post-treatment rescued cells altered by UV exposure from death and thus altering cell fate. Our results also indicated that LLLT source light is non-toxic to HeLa cells. Taken together, the results demonstrated the beneficial effects of LLLT in relieving the signs of skin aging, and on the cellular level, LLLT has double effects; it prevented and also protected HeLa cells against UV-mediated cell death. Our results are consistent with other findings that demonstrated that LLLT facilitates collagen synthesis, keratinocyte cell motility and growth factor release, increases the regenerative potential of biological tissues and increases the neovascularization and formation of regenerative tissue (Yu et al., 1994; Kreisler et al., 2002; Basso et al., 2013) . Others authors suggest that the mechanism of low-level lasers is based on the absorption of laser-emitted photons by the flavin mononucleotide enzyme (FMN) and cytochrome c oxidase, which are activators of cellular respiration. Through this absorption, the synthesis of ATP from ADP is accelerated, and redox mechanisms are excited, which in turn activates cellular metabolism and cellular physiology (Lubart et al., 2005; Karu, 2008; Tafur and Mills, 2008) . In this manner, LLLT may act to promote proliferation and/ or cellular homeostasis.
In summary, our results suggest that LLLT significantly reduced the signs of facial skin aging, including wrinkles and the loss of firmness, prevented and protected human epithelioid cells from cell death induced by UV irradiation. We report here for the first time the benefits of LLLT on relieving facial signs of aging, and we believe that these results will be of clinical relevance in helping clinicians to prevent and to attenuate photoaging and the development of skin cancer.
